Scholarlink

<p>Ultraviolet radiation (UVR) exposure drives skin photodamage, which constitutes the fundamental basis of both photoaging and photocarcinogenesis, by disrupting mitochondrial homeostasis and inducing reactive oxygen species (ROS) accumulation. Although B7-H3 (CD276) is recognized as an immune-checkpoint molecule involved in tumor metabolism, its role in UVR-induced cutaneous photodamage and the associated redox imbalance remains undefined. Here we show that B7-H3 is elevated in acute and chronic photodamaged human skin as well as in UVR-induced mouse (female) and cell models. Genetic deletion or antibody blockade of B7-H3 attenuates ROS accumulation, preserves mitochondrial function, and reduces photodamage. Mechanistically, B7-H3 interacts with integrin α2 (ITGA2) to impair antioxidant signaling by inhibiting the nuclear translocation of nuclear factor erythroid 2-related factor 2 (NRF2) and disrupting the nuclear respiratory factor 1 (NRF1)-transcription factor A, mitochondrial (TFAM) pathway, ultimately disrupting mitochondrial biogenesis and redox balance. Furthermore, treatment with an anti-B7-H3 blocking monoclonal antibody alleviates photodamage and preserves mitochondrial function. Collectively, these findings indicate that the skin-resident B7-H3/ITGA2 interaction contributes to photodamage via disrupting TFAM expression, suggesting that targeting B7-H3 may represent a promising therapeutic strategy for skin photodamage and related disorders.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

B7-H3 promotes skin photodamage through ITGA2-NRF2-TFAM-mediated mitochondrial oxidative stress

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月28日

查看全文
  • Yuanyuan Jia,
  • Qiange Zhang,
  • Fangying Su,
  • Yuan Zhu,
  • Siji Chen,
  • Jingyi Yang,
  • Qiuyu Mao,
  • Yiwen Zhang,
  • Yuting Yang,
  • Sisi Ding,
  • Cuiping Liu,
  • Xueguang Zhang,
  • Dan Luo,
  • Wei Min,
  • Lei Cao

摘要

Ultraviolet radiation (UVR) exposure drives skin photodamage, which constitutes the fundamental basis of both photoaging and photocarcinogenesis, by disrupting mitochondrial homeostasis and inducing reactive oxygen species (ROS) accumulation. Although B7-H3 (CD276) is recognized as an immune-checkpoint molecule involved in tumor metabolism, its role in UVR-induced cutaneous photodamage and the associated redox imbalance remains undefined. Here we show that B7-H3 is elevated in acute and chronic photodamaged human skin as well as in UVR-induced mouse (female) and cell models. Genetic deletion or antibody blockade of B7-H3 attenuates ROS accumulation, preserves mitochondrial function, and reduces photodamage. Mechanistically, B7-H3 interacts with integrin α2 (ITGA2) to impair antioxidant signaling by inhibiting the nuclear translocation of nuclear factor erythroid 2-related factor 2 (NRF2) and disrupting the nuclear respiratory factor 1 (NRF1)-transcription factor A, mitochondrial (TFAM) pathway, ultimately disrupting mitochondrial biogenesis and redox balance. Furthermore, treatment with an anti-B7-H3 blocking monoclonal antibody alleviates photodamage and preserves mitochondrial function. Collectively, these findings indicate that the skin-resident B7-H3/ITGA2 interaction contributes to photodamage via disrupting TFAM expression, suggesting that targeting B7-H3 may represent a promising therapeutic strategy for skin photodamage and related disorders.